Previous studies had shown that LAMP5 could serve as a prognostic signature to predict survival in patients with gastric cancer, and its high expression levels could accurately estimate KMT2A-r in acute leukemias (Wang et al., 2017; Lopes et al., 2022). This evidence concerns the gene LAMP5 and acute leukemia.